Table 5.
Initial data of plasma levels of low insulin sensitivity subjects (homeostatic model assessment of insulin resistance (HOMA-IR) ≥ 1·7) in the main study
(Mean values and standard deviations; numbers of subjects)
| Test: GLUCODIA™ | Control: casein | |||
|---|---|---|---|---|
| Mean | sd | Mean | sd | |
| Subjects (n) | 20 | 16 | ||
| Male | 10 | 6 | ||
| Female | 10 | 10 | ||
| Fasting plasma glucose (mg/dl)* | 102 | 9 | 98 | 8 |
| Insulin (μU/ml) | 15·2 | 5·7 | 13·7 | 3·9 |
| HOMA-IR | 3·9 | 1·5 | 3·3 | 1·0 |
| HbA1c (%) | 5·66 | 0·26 | 5·49 | 0·25 |
| TAG (mg/dl)† | 146 | 69 | 132 | 48 |
| Total cholesterol (mg/dl)‡ | 195 | 37 | 193 | 23 |
| LDL-cholesterol (mg/dl)‡ | 120 | 33 | 117 | 21 |
| HDL-cholesterol (mg/dl)‡ | 51 | 12 | 50 | 9 |
| NEFA (mEq/l) | 539 | 323 | 398 | 188 |
| AST (IU/l) | 24·4 | 10·1 | 26·5 | 6·3 |
| ALT (IU/l) | 36·1 | 14·3 | 33·9 | 11·4 |
| γ-GTP (IU/l) | 28·3 | 18·3 | 29·8 | 28·0 |
HbA1c, glycated Hb; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyltransferase.
* To convert glucose from mg/dl to mmol/l, multiply by 0·0555.
† To convert TAG from mg/dl to mmol/l, multiply by 0·0113.
‡ To convert cholesterol from mg/dl to mmol/l, multiply by 0·0259.